Manuscripts and Publications
Filters: Keyword is Female [Clear All Filters]
Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.. J Acquir Immune Defic Syndr. 61(4):499-506.
.
2012. Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.. AIDS Patient Care STDS. 26(4):193-6.
.
2012. Adolescent decision making about participation in a hypothetical HIV vaccine trial.. Vaccine. 33(11):1331-7.
.
2015. Health related quality of life and psychosocial correlates among HIV-infected adolescent and young adult women in the US.. AIDS Educ Prev. 23(4):367-81.
.
2011. .
2019. Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.. Antimicrob Agents Chemother. 55(11):5294-9.
.
2011. Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.. AIDS. 20(3):353-60.
.
2006. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.. AIDS. 21(18):2387-97.
.
2007. Identification of HIV-infected 12- to 24-year-old men and women in 15 US cities through venue-based testing.. Arch Pediatr Adolesc Med. 164(3):273-6.
.
2010. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.. AIDS Behav. 18(4):686-96.
.
2014. Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
.
2015. Self-Efficacy for Sexual Risk Reduction and Partner HIV Status as Correlates of Sexual Risk Behavior Among HIV-Positive Adolescent Girls and Women.. AIDS Patient Care STDS. 29(6):346-53.
.
2015. Exchange of Sex for Drugs or Money in Adolescents and Young Adults: An Examination of Sociodemographic Factors, HIV-Related Risk, and Community Context.. J Community Health. 42(1):90-100.
.
2017. A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
.
2014. An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.. JAMA Pediatr. 167(3):289-96.
.
2013. Examination of Behavioral, Social, and Environmental Contextual Influences on Sexually Transmitted Infections in At Risk, Urban, Adolescents, and Young Adults.. Sex Transm Dis. 45(8):542-548.
.
2018. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization.. Am J Public Health. 102(9):1751-7.
.
2012. Interaction Effects of Neighborhood Disadvantage and Individual Social Support on Frequency of Alcohol Use in Youth Living with HIV.. Am J Community Psychol. 61(3-4):276-284.
.
2018. Young Women Living with HIV: Outcomes from a Targeted Secondary Prevention Empowerment Pilot Trial.. AIDS Patient Care STDS. 30(5):229-35.
.
2016. EVOLUTION--taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV.. AIDS Patient Care STDS. 28(1):33-42.
.
2014. Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.. J Acquir Immune Defic Syndr. 71(1):38-46.
.
2016. Psychological symptoms among 2032 youth living with HIV: a multisite study.. AIDS Patient Care STDS. 29(4):212-9.
.
2015. Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS.. Drug Alcohol Depend. 151:173-80.
.
2015. Age-concordant and age-discordant sexual behavior among gay and bisexual male adolescents.. Arch Sex Behav. 41(2):441-8.
.
2012. "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.. AIDS Behav. 16(7):1761-74.
.
2012. Creating partnerships for HIV prevention among YMSM: the Connect Protect® Project and House and Ball Community in Philadelphia.. J Prev Interv Community. 40(2):165-75.
.
2012. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
.
2016. Gendered powerlessness in at-risk adolescent and young women: an empirical model.. AIDS Care. 32(10):1333-1342.
.
2020. Mobilizing communities around HIV prevention for youth: how three coalitions applied key strategies to bring about structural changes.. AIDS Educ Prev. 22(1):15-27.
.
2010. Examining differences in types and location of recruitment venues for young males and females from urban neighborhoods: findings from a multi-site HIV prevention study.. J Urban Health. 86(1):31-42.
.
2009. Victimization and sexual risk behavior in young, HIV positive women: exploration of mediators.. AIDS Behav. 16(4):999-1010.
.
2012. Child abuse in young, HIV-positive women: linkages to risk.. Qual Health Res. 19(12):1755-68.
.
2009. Strategies and outcomes of HIV status disclosure in HIV-positive young women with abuse histories.. AIDS Patient Care STDS. 27(3):191-200.
.
2013. .
2019. .
2010. The role of community resource assessments in the development of 15 adolescent health community-researcher partnerships.. Prog Community Health Partnersh. 2(1):31-9.
.
2008. Patterns of disclosure among youth who are HIV-positive: a multisite study.. J Adolesc Health. 50(3):315-7.
.
2012. Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities.. J Adolesc Health. 46(3):278-83.
.
2010. A Multi-Site Study of Social Cognitive Factors Related to Adherence Among Youth Living With HIV in the New Era of Antiretroviral Medication.. J Pediatr Psychol. 44(1):98-109.
.
2019. Project ORE: A friendship-based intervention to prevent HIV/STI in urban African American adolescent females.. Health Educ Behav. 37(1):115-32.
.
2010. .
2016. HIV viral load levels and CD4+ cell counts of youth in 14 cities.. AIDS. 28(8):1213-9.
.
2014. Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.. JAMA Pediatr. 169(3):256-63.
.
2015. Substance abuse treatment for HIV infected young people: an open pilot trial.. J Subst Abuse Treat. 46(2):244-50.
.
2014. Profiles of Risk Among HIV-Infected Youth in Clinic Settings.. AIDS Behav. 19(5):918-30.
.
2015. Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings.. AIDS Care. 23(11):1492-9.
.
2011. Desire for pregnancy and risk behavior in young HIV-positive women.. AIDS Patient Care STDS. 26(3):173-80.
.
2012. .
2017. The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.. AIDS Behav. 21(7):1868-1877.
.
2017. Anticipated HIV Stigma and Delays in Regular HIV Testing Behaviors Among Sexually-Active Young Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women.. AIDS Behav. 22(2):522-530.
.
2018. A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.. Sex Transm Infect. 94(4):304-308.
.
2018. Prevalence and correlates of substance use among youth living with HIV in clinical settings.. Drug Alcohol Depend. 169:11-18.
.
2016. The moderating role of resilience resources in the association between crime exposure and substance use among young sexual minority men.. Subst Use Misuse. 54(11):1787-1798.
.
2019. Tobacco Use and Sustained Viral Suppression in Youth Living with HIV.. AIDS Behav. 22(6):2018-2025.
.
2018. Use of geographic information systems for planning HIV prevention interventions for high-risk youths.. Am J Public Health. 97(11):1974-81.
.
2007. Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.. Cult Health Sex. 14(2):151-66.
.
2012. Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.. J Adolesc Health. 57(1):113-9.
.
2015. Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.. AIDS Patient Care STDS. 30(7):324-38.
.
2016. Transgender and Other Gender-Diverse Youth's Progression Through the HIV Continuum of Care: Socioecological System Barriers.. AIDS Patient Care STDS. 33(1):32-43.
.
2019. Stigma reduction in adolescents and young adults newly diagnosed with HIV: findings from the Project ACCEPT intervention.. AIDS Patient Care STDS. 28(10):543-54.
.
2014. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.. Clin Infect Dis. 66(2):220-228.
.
2018. Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.. Pediatr Infect Dis J. 34(4):406-8.
.
2015. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.. Clin Infect Dis. 54(7):1013-25.
.
2012. Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.. Antivir Ther. 19(6):613-8.
.
2014. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
.
2013. Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.. Antivir Ther. 23(7):623-628.
.
2018. Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.. J Clin Endocrinol Metab. 97(11):4004-13.
.
2012. Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions.. AIDS Behav. 24(8):2239-2243.
.
2020. Using technology to assess and intervene with illicit drug-using persons at risk for HIV.. Curr Opin HIV AIDS. 12(5):458-466.
.
2017. What HIV-positive young women want from behavioral interventions: a qualitative approach.. AIDS Patient Care STDS. 26(5):291-7.
.
2012. Evaluating the acceptability and feasibility of Project ACCEPT: an intervention for youth newly diagnosed with HIV.. AIDS Educ Prev. 23(2):128-44.
.
2011. .
2018. Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.. J Acquir Immune Defic Syndr. 47(1):86-92.
.
2008. Youth living with HIV and partner-specific risk for the secondary transmission of HIV.. Sex Transm Dis. 36(7):439-44.
.
2009. Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.. J Acquir Immune Defic Syndr. 68(2):169-77.
.
2015. Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV.. PLoS One. 11(4):e0151106.
.
2016. HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination.. AIDS Behav. 22(6):1826-1834.
.
2018. Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.. J Acquir Immune Defic Syndr. 75(2):241-245.
.
2017. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.. Sex Transm Dis. 42(5):246-52.
.
2015. Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.. J Acquir Immune Defic Syndr. 61(3):390-9.
.
2012. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.. J Med Virol. 88(11):1944-52.
.
2016. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.. Clin Infect Dis. 57(5):735-44.
.
2013. Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.. J Adolesc Health. 50(5):464-70.
.
2012. Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.. AIDS. 30(6):889-98.
.
2016. The HIV Continuum of Care for Adolescents and Young Adults Attending 13 Urban US HIV Care Centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative.. J Acquir Immune Defic Syndr. 84(1):92-100.
.
2020. Safety and Effectiveness of Same-Day Chlamydia trachomatis and Neisseria gonorrhoeae Screening and Treatment Among Gay, Bisexual, Transgender, and Homeless Youth in Los Angeles, California, and New Orleans, Louisiana.. Sex Transm Dis. 47(1):19-23.
.
2020. Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.. AIDS Res Hum Retroviruses. 35(8):746-754.
.
2019. .
2008. Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.. J Adolesc Health. 55(2):254-9.
.
2014. HIV Continuum of Care for Youth in the United States.. J Acquir Immune Defic Syndr. 77(1):110-117.
.
2018. Comprehension of a simplified assent form in a vaccine trial for adolescents.. J Med Ethics. 39(6):410-2.
.
2013. .
2015. .
2009. Young women's experience with using videoconferencing for the assessment of sexual behavior and microbicide use.. Telemed J E Health. 19(11):866-71.
.
2013. Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth.. J Pediatr Psychol. 41(4):419-28.
.
2016. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
.
2013. Predictors of medication adherence in high risk youth of color living with HIV.. J Pediatr Psychol. 35(6):593-601.
.
2010. Stressors and sources of support: the perceptions and experiences of newly diagnosed Latino youth living with HIV.. AIDS Patient Care STDS. 26(5):281-90.
.
2012. .
2012. .
2010.